Ensuring Continuous Access to TB TreatmentSep 7, 2016
UNDP and StopTB Partnership Training on QuanTB
Ashgabat, 30-31 August 2016: The United Nations Development Programme (UNDP) together with the StopTB Partnership and in cooperation with Systems for Improved Access to Pharmaceutical and Services (SIAPS) Program introduced a new tool for monitoring and management of the medicines to treat tuberculosis (TB) throughout Turkmenistan. During the two-day practical training, UNDP has taught 16 TB doctors from regional and central facilities about the benefits and use of the “QuanTB”.
QuanTB is an electronic desktop tool developed by SIAPS. It transforms complicated calculations into a user-friendly dashboard, displaying key information for managing medicines assigned to the patients. It contributes to the implementation of the national TB programme by counting how much medicine is used, how much is left, what medicine has expired and when new procurement needs to be made.
“In 2013 Turkmenistan started treatment of multidrug-resistant (MDR) TB. Since then, the National TB Programme has considerably scaled up its coverage and treatment of MDR-TB using new diagnostic tools such as Xpert technology, which rapidly increases the number of diagnosed cases, and thus the quantities of medicines needed. Moreover, treatment regimens for each patient might change due to drug resistance or intolerance. Therefore, TB specialist must take into account a list of medicines, their expiry dates and patient numbers in order to manage the risks of stock out,” states Dr. Batyr Chapau, UNDP Senior TB Specialist.
The training was held under the new grant cycle of the Global Fund to Fight AIDS, Tuberculosis and Malaria “Ensuring universal access to high-quality diagnosis and treatment of drug resistant tuberculosis (DR-TB) in Turkmenistan”.
Participants of the training were introduced to the new tool, familiarized with its interface and technical features. During the practical training, participants exercised the input of numbers of cases enrolled and planned for treatment, various treatment regimens, shelf lives of drugs; they also made a sample dashboard alerting on the supply problems, and then planned procurements based on the entered parameters.
“Up to now the National TB Programme of Turkmenistan managed the second line TB drugs very well. However, with the scaling up of the treatment coverage the use of QuanTB tool is extremely important. If used regularly by the National TB Programme staff, it will help the Ministry of Health to ensure adequate stocks of drugs for treatment of MDR-TB without expiries of expensive drugs and thus ensuring efficient use of the funds,” says Maya Kavtradze, Regional Technical Advisor of the Stop TB Partnership Global Drug Facility who came to Turkmenistan to conduct the training.
QuanTB is expected to be introduced in Turkmenistan by the end of 2016 at the level of regional and central TB facilities.Contact information